Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
The risks that can come from buying these assets are precisely why we started StockStory — to isolate the long-term winners from the losers so you can invest with confidence. Keeping that in mind, here are three growth stocks expanding their competitive advantages.
HEICO (HEI)
One-Year Revenue Growth: +18.8%
Founded in 1957, HEICO (NYSE: HEI) manufactures and services aerospace and electronic components for commercial aviation, defense, space, and other industries.
Why Should You Buy HEI?
- Annual revenue growth of 18.3% over the last two years was superb and indicates its market share increased during this cycle
- Earnings growth has trumped its peers over the last two years as its EPS has compounded at 32.7% annually
- HEI is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders
HEICO’s stock price of $377.83 implies a valuation ratio of 56.9x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
First Solar (FSLR)
One-Year Revenue Growth: +27.3%
Headquartered in Arizona, First Solar (NASDAQ: FSLR) specializes in manufacturing solar panels and providing photovoltaic solar energy solutions.
Why Is FSLR a Good Business?
- Annual revenue growth of 23.3% over the last two years was superb and indicates its market share increased during this cycle
- Free cash flow margin is now positive, indicating the company has achieved financial self-sustainability
- Returns on capital are growing as management capitalizes on its market opportunities
At $237.04 per share, First Solar trades at 11.7x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.
Oscar Health (OSCR)
One-Year Revenue Growth: +32%
Founded in 2012 to simplify the notoriously complex American healthcare system, Oscar Health (NYSE: OSCR) is a technology-focused health insurance company that offers individual and small group health plans through its cloud-native platform.
Why Is OSCR a Top Pick?
- Annual revenue growth of 42.6% over the last two years was superb and indicates its market share increased during this cycle
- Earnings per share grew by 31.5% annually over the last four years and trumped its peers
- Free cash flow margin expanded by 19.9 percentage points over the last five years, providing additional flexibility for investments and share buybacks/dividends
Oscar Health is trading at $31.40 per share, or 29.3x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Stocks We Like Even More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
